Abrégé

Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux

Produits et services

Advertising and marketing services in the field of pharmaceuticals and healthcare; advertising and promotional services for pharmaceutical preparations acting on the central nervous system and for pharmaceutical preparations for the treatment of central nervous system diseases and disorders, sleep disorders, narcolepsy, cata-plexy, excessive daytime sleepiness and other sleep related diseases; development and implementation of unbranded patient and healthcare professional acquisition, awareness, and engagement campaigns relating to central nervous system disorders and diseases and sleep disorders and diseases, via print, digital, social media, and online channels Educational services, namely, providing non-downloadable online articles, videos, webinars, and other educational materials in the field of central nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; organizing and conducting educational programs, workshops, and seminars for, caregivers, and healthcare professionals in the field of central nervous system disorders and diseases and sleep disorders and diseases Providing health information in the field of central nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing a website featuring information on symptoms, diagnosis, and treatment options for central nervous system disorders and diseases and sleep disorders and diseases

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61P 25/20 - HypnotiquesSédatifs

Abrégé

Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Produits et services

Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific research, biochemical research, and pharmaceutical research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; scientific study and research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related disease; testing of pharmaceuticals; provision of pharmaceutical research information and chemical and biochemical analysis for research purposes. Provision of pharmaceutical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases.

Produits et services

Providing temporary use of non-downloadable software for managing patient enrollment in clinical trials; Software as a service (SaaS) services featuring software for patient registration and data management in clinical studies; Providing an online platform for managing patient enrollment and participation in clinical trials; Providing an interactive web site featuring technology that enables users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring scientific research information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of scientific information by means of an interactive web site in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; patient enrollment and management for clinical trials

Produits et services

Providing medical information to patients and healthcare professionals in the field of clinical trials; Provision of medical information and advice in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring medical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

Abrégé

Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

Produits et services

(1) Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific research, biochemical research, and pharmaceutical research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; scientific study and research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related disease; testing of pharmaceuticals; provision of pharmaceutical research information and chemical and biochemical analysis for research purposes. (2) Provision of pharmaceutical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases.

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Packaged formulations of gamma-hydroxybutyrate having improved dissolution and chemical stability after storage for up to at least 72 months, packaging for supporting said stability, and therapeutic uses thereof.

Classes IPC  ?

• A61K 9/50 - Microcapsules
• A61J 1/10 - Récipients du type sac
• A61J 1/14 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques DétailsAccessoires à cet effet
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 47/02 - Composés inorganiques
• A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
• A61K 47/38 - CelluloseSes dérivés
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux

Produits et services

Scientific and technological services, namely, scientific real world evidence studies and research in the fields of medicine, the prevention, treatment and management of illness, and health care delivery; Providing temporary use of non-downloadable software for collecting, analyzing, and reporting real-world evidence (RWE) data; Medical and scientific research in the field of pharmaceuticals and clinical trials; Medical and scientific research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Produits et services

Medical services, namely, conducting real-world evidence sleep studies for medical diagnostic or treatment purposes; Providing medical information and medical data analysis in the field of pharmaceuticals and healthcare for medical diagnostic or treatment purposes; Providing medical information and medical data analysis in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases for medical diagnostic or treatment purposes; Consulting services in the field of healthcare and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals for medical diagnostic or treatment purposes; Providing a website featuring information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals and participation in real-world evidence sleep studies for medical diagnostic or treatment purposes; Providing a website featuring medical information about nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Produits et services

Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific research, biochemical research, and pharmaceutical research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; scientific study and research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related disease; testing of pharmaceuticals; provision of medical and scientific research information in the field of pharmaceuticals in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; provision of pharmaceutical information in the fields of pharmaceutical research and chemical and biochemical analysis for research purposes Provision of pharmaceutical information being information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, insomnia and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy, cataplexy, insomnia and other sleep related diseases; medications for central nervous system disorders and diseases and sleep disorders and diseases

Abrégé

Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/191 - Acides acycliques ayant plusieurs groupes hydroxyle, p. ex. acide gluconique
• A61P 25/20 - HypnotiquesSédatifs

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

Produits et services

Patient assistance programs, namely, business administration of prescription drug reimbursement programs Patient assistance programs, namely, providing financial assistance to pay prescription drug expenses, out-of-pocket expenses, and prescription co-pays

Produits et services

Patient assistance programs, namely, business administration of prescription drug reimbursement programs Patient assistance programs, namely, providing financial assistance to pay prescription drug expenses, out-of-pocket expenses, and prescription co-pays

Produits et services

Administration of a program for enabling patients to obtain discounts on prescription drug spending through a copay discount program; administration of pharmacy reimbursement programs and co-pay support programs for patients; patient benefits programs in connection with pharmaceutical services Patient support and assistance in connection with pharmaceutical services, namely, providing information about eligibility for financial assistance provided through patient benefits programs

Produits et services

Administration of a discount program for medical patients featuring product savings programs, product trial offers, and online tools to assist with obtaining prior authorizations and links to patient assistance programs which provide products to patients who are unable to afford the cost of their medication Charitable services, namely, patient assistance program to provide pharmaceuticals free of charge or at reduced cost to patients; providing information relating to diagnostic, prophylactic and therapeutics properties of pharmaceuticals; providing information to patients in the field of administering medications; Medical services, namely, providing information regarding medical conditions, treatment and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals and patients regarding medical conditions and treatment; providing a website featuring information about medical conditions and treatment; providing a website featuring information on medical practice management

Produits et services

Administration of a discount program for medical patients featuring product savings programs, product trial offers, and online tools to assist with obtaining prior authorizations and links to patient assistance programs which provide products to patients who are unable to afford the cost of their medication Charitable services, namely, patient assistance program to provide pharmaceuticals free of charge or at reduced cost to patients; providing information relating to diagnostic, prophylactic and therapeutics properties of pharmaceuticals; providing information to patients in the field of administering medications; Medical services, namely, providing information regarding medical conditions, treatment and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals and patients regarding medical conditions and treatment; providing a website featuring information about medical conditions and treatment; providing a website featuring information on medical practice management

Produits et services

Providing an interactive web site featuring technology that enables users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring scientific research information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of scientific information by means of an interactive web site in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases Provision of medical information and advice in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring medical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Produits et services

Providing an interactive web site featuring technology that enables users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring scientific research information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of scientific information by means of an interactive web site in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases Provision of medical information and advice in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring medical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Abrégé

Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

(1) Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

Providing technical information in the field of pharmaceutical manufacturing in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases Pharmaceutical preparations and medications for use in the treatment of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases Provision of pharmaceutical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases Medical and pharmaceutical consultation in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical information to patients and medical professionals in the form of reports of in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

(1) Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

(1) Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

(1) Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

Providing online non-downloadable software enabling users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases via an interactive website. Provision of pharmaceutical information and advice relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases via an interactive website.

Produits et services

Providing support services in the nature of medical information to physicians and patients regarding the recognition, screening, diagnosis, and management of narcolepsy and excessive sleepiness; medical information; providing medical information; providing medical information regarding the management of narcolepsy and excessive sleepiness

Produits et services

Providing information featuring technology that enables users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases via an interactive website; providing information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases via an interactive website. Provision of pharmaceutical information and advice relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases.

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Abrégé

Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.

Classes IPC  ?

• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Produits et services

(1) Providing information featuring technology that enables users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases via an interactive website; provision of scientific information by means of an interactive web site in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases. (2) Providing an interactive web site featuring technology that enables users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; Providing an interactive web site featuring information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases (3) Provision of pharmaceutical information and advice relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Produits et services

(1) Providing online non-downloadable software enabling users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases via an interactive website. (2) Provision of medical information and advice in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases. (3) Providing an interactive web site featuring scientific research information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of scientific information by means of an interactive web site in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases.

Produits et services

Provision of medical information and advice in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice via a website in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of medical information and advice in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring medical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Produits et services

Providing an interactive web site featuring technology that enables users to search, locate and access health care and medical service providers in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; providing an interactive web site featuring scientific research information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; provision of scientific information by means of an interactive web site in the field of pharmaceuticals relating to nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Produits et services

(1) Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, excessive daytime sleepiness and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases, namely, somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/22 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

Abrégé

Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

Pharmaceutical compositions that include a bi-modal, mutiparticulate mixtures of immediate release particles and modified release particles to provide a therapeutic effect of methylphenidate, dexmethylphenidate, structural analogs of methylphenidate or dexmethylphenidate, pharmaceutical salts thereof, and mixtures thereof overextended periods of time.

Classes IPC  ?

• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, insomnia and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases.

Produits et services

(1) Pharmaceutical preparation acting on the central nervous system for treating somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, insomnia and other sleep related diseases; Medication for central nervous system disorders and diseases and sleep disorders and diseases, namely, somnipathy, chronic and acute fatigue, and sleep-wake cycle disorders.

Produits et services

Pharmaceutical preparation acting on the central nervous system; pharmaceutical preparation for the treatment of central nervous system diseases and disorders; pharmaceutical preparation for the treatment of sleep disorders; pharmaceutical preparation for the treatment of narcolepsy, cataplexy, insomnia and other sleep related diseases; medication for central nervous system disorders and diseases and sleep disorders and diseases

Abrégé

Packaged formulations of gamma-hydroxybutyrate having improved dissolution and chemical stability, packaging for supporting said stability, and therapeutic uses thereof.

Classes IPC  ?

• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Produits et services

Orally administrable, microparticulate, pharmaceutical formulations in the nature of drug delivery agents that allow for the controlled release of one or more medicinal or nutritional active principles; orally administrable powders, suspensions, suspension powders, and capsules in the nature of drug delivery agents for providing the controlled release of one or more medicinal or nutritional active principles

Produits et services

Medical and product research and development services notably in the field of microparticulate systems that allows for the controlled release of oral dosage formulations of drugs

Abrégé

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Classes IPC  ?

• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/50 - Microcapsules
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque

Abrégé

The invention relates to a pharmaceutical composition comprising a plurality of controlled-release coated microparticles each comprising a floating core, on the surface of which is deposited a layer containing at least one active principle, said layer being covered with a controlled-release coating, characterized by the fact that said floating core is composed of cellulose acetate phthalate and has an apparent density of less than or equal to 0.6 g/mL and said coated microparticles have a density of less than or equal to 0.7 g/mL.

Classes IPC  ?

• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/50 - Microcapsules
• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61K 31/155 - Amidines (), p. ex. guanidine (H2N-C(=NH)-NH2), isourée (HN=C(OH)NH2), isothiourée (HN=C(SH)-NH2)
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 31/403 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil condensés avec des carbocycles, p. ex. carbazole

Produits et services

Pharmaceutical preparations and medications for use in the treatment of hypotension in the setting of anesthesia; Pharmaceutical preparations and medications; Pharmaceutical products and preparations for the treatment of autoimmune diseases, bacterial infections, chronic anemia, hypotension, disorders of the musculo-skeletal system, for maintaining blood pressure, for the reversal of the effects of anesthesia, for the reversal of the effects of non-depolarizing neuromuscular blocking agents; chemical preparations for medical and veterinary purposes for injection or oral administration, namely, a drug delivery system in the form of coatings, tablets that provide continuous and controlled release of active ingredients in a wide variety of therapeutic agents to human patients; encapsulated pharmaceutical preparations for the prolonged and controlled release of active ingredients, for the treatment of a wide variety of diseases and disorders; injectable medication used to reverse anesthesia; medication used to maintain blood pressure. Provision of pharmaceutical information in the fields of pharmaceutical research and chemical and biochemical analysis. Provision of pharmaceutical information and advice.

Produits et services

Pharmaceutical preparations and medications for use in the treatment of [ hypotension in the setting of anesthesia; pharmaceutical preparations and medications for treating pain management, respiratory diseases and disorders, allergic disorders, gastrointestinal disorders, ] sleep disorders [, dermatological conditions, pulmonary diseases, obstetrics and gynecology; pharmaceutical products, namely, pharmaceutical agents and preparations for the treatment of autoimmune diseases, bacterial infections, chronic anemia, hypotension, disorders of the musculo-skeletal system, for maintaining blood pressure, for the reversal of the effects of anesthesia, for the reversal of the effects of non-depolarizing neuromuscular blocking agents ] ; chemical preparations for medical [ and veterinary ] purposes for injection or oral administration, namely, a drug delivery system in the form of coatings, tablets that provide continuous and controlled release of active ingredients in a wide variety of therapeutic agents to human patients; drug delivery agents in the form of encapsulated pharmaceutical preparations for the prolonged and controlled release of active ingredients, for the treatment of a wide variety of diseases and disorders [ ; injectable medication used to reverse anesthesia; medication used to maintain blood pressure ] Provision of pharmaceutical information in the fields of pharmaceutical research and chemical and biochemical analysis for research purposes Provision of pharmaceutical advice; provision of pharmaceutical information, namely, the diagnostic, prophylactic and therapeutic properties of pharmaceuticals and instructional information for use of the pharmaceutical products

Abrégé

The present invention provides stable pharmaceutical antibody formulations, including liquid formulations and lyophilized formulations, comprising an anti-IL-4/anti-IL-13 bispecific antibody, a polyaminoacid consisting of glutamic acid or aspartic acid or both randomly grafted with Vitamin E, and a cryoprotectant, wherein the formulation has a salt concentration of 50 m M or less. The present invention also provides stable pharmaceutical antibody formulations, including liquid formulations and lyophilized formulations, comprising an anti-IL-4/anti-IL-13 bispecific antibody, a polyaminoacid consisting of glutamic acid or aspartic acid or both randomly grafted with Vitamin E, a cryoprotectant, and a buffering system, wherein the pH of the formulation is about pH 7, and wherein the formulation has a salt concentration of 50 mM or less. The formulations may, optionally, further comprise a surfactant, or a stabilizing agent, or both. The present invention includes methods for making such formulations. The formulations can be used in the treatment of various diseases.

Classes IPC  ?

• A61K 39/395 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire
• C07K 16/24 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des cytokines, des lymphokines ou des interférons